Pathological Assessment of Men with Grade Group 2 Prostate Cancer

Pathological Assessment of Men with Grade Group 2 Prostate Cancer

Purpose: A variety of treatment options are now available for men with localized prostate cancer (PC); however, there is still debate in determining how and when to intervene for Grade Group (GG) 2 disease. Our study aims to formulate strategies to identify men at risk of upgrading and having adve...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anika Jain, Lawrence Kim, Manish I. Patel
Format:	Article
Language:	English
Published:	Korean Society for Sexual Medicine and Andrology 2025-07-01
Series:	The World Journal of Men's Health
Subjects:	active surveillance grade group 2 pathology prostate cancer prostatic neoplasms watchful waiting
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer
by: Frederik F. Thomsen, et al.
Published: (2024-04-01)

Correlation of expression of Cyclin D1 and E-cadherin with gleason grade, serum prostate specific antigen levels and prostatic volume in prostatic carcinoma
by: C Aatirah, et al.
Published: (2023-07-01)

Management of Small Renal Masses: Literature and Guidelines Review
by: Antonio Silvestri, et al.
Published: (2025-08-01)

Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men
by: Torben Brøchner Pedersen, et al.
Published: (2025-01-01)

Intralesional and perilesional radiomics strategy based on different machine learning for the prediction of international society of urological pathology grade group in prostate cancer
by: Zhiping Li, et al.
Published: (2025-07-01)

Targeted Prostate Biopsies Overestimate International Society of Urological Pathology Grade Group, Particularly in Smaller Tumors
by: Lisa J. Kroon, et al.
Published: (2025-05-01)

Unveiling key pathomic features for automated diagnosis and Gleason grade estimation in prostate cancer
by: Valentina Brancato, et al.
Published: (2025-07-01)

TWIK Complex Expression in Prostate Cancer: Insights into the Biological and Therapeutic Significances of Potassium Ion Channels in Clinical Cancer
by: Abdulaziz Alfahed
Published: (2025-05-01)

Factor of combined pathology in geriatric patients with prostate adenoma
by: I. G. Leshchenko, et al.
Published: (2020-12-01)

Association of Perineural Invasion of Adenocarcinoma in Prostate Biopsy with Pathological and Clinical Outcomes
by: Rita Rueangrong, et al.
Published: (2025-08-01)

Estimated length of stay calculated by “diagnosisrelated groups” in patients with prostate cancer: a retrospective analysis
by: Daniel Melecchi Freitas, et al.
Published: (2021-10-01)

SIU-ICUD: Localized Prostate Cancer: Pathological Factors That Influence Outcomes and Management
by: Gladell P. Paner, et al.
Published: (2025-06-01)

Significance of microvessel density in prostate cancer core biopsy
by: Salapura-Dugonjić Aleksandra, et al.
Published: (2015-01-01)

Metastatic prostate cancer presenting as a posterior mediastinal mass: A rare presentation
by: Muhammad Haider, et al.
Published: (2023-03-01)

Prostatic calculi cause osteoblastic immunophenotype of prostate cancer
by: A. M. Piddubnyi, et al.
Published: (2019-09-01)

Cost-effectiveness of watchful waiting versus immediate emergency department transfer after epinephrine autoinjector use in Canada
by: Yiwei Yin, et al.
Published: (2025-01-01)

The Rebound Effect of the COVID-19 Pandemic on Clinically Significant Prostate Cancer Diagnosis
by: Antonio Fanelli, et al.
Published: (2025-03-01)

A visualized machine learning model using noninvasive parameters to differentiate men with and without prostatic carcinoma before biopsy
by: Wenting Zhou, et al.
Published: (2025-07-01)

Sonographic diagnostics, prevalence and age-based dynamics of the manifestation of prostate gland pathologies in dogs
by: V. R. Serhiienko, et al.
Published: (2024-12-01)

Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea
by: Won Tae Kim, et al.
Published: (2025-03-01)

Metastatic bone lesions of men in combination with an increase in serum PSA from the point of view of diagnosing carcinomas of unknown primary localization
by: O. V. Poslavska, et al.
Published: (2019-05-01)

Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity
by: Jason Gurewitz, et al.
Published: (2025-09-01)

Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?
by: Alvin Lee, et al.
Published: (2016-01-01)

Neuroendocrine differentiation in prostate cancer
by: Cerović Snežana J., et al.
Published: (2004-01-01)

Association of Serum PSA, fPSA, and CEA Levels with Prognosis and Clinicopathological Characteristics in Prostate Cancer
by: Ahamed Y, et al.
Published: (2025-08-01)

Role and application of diffusion-weighted imaging in evaluation of prostate cancer
by: Amol Madanlal Lahoti, et al.
Published: (2018-01-01)

Prostate cancer volume associates with preoperative plasma levels of testosterone that independently predicts high grade tumours which show low densities (quotient testosterone/tumour volume)
by: Antonio B. Porcaro, et al.
Published: (2016-01-01)

Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomes
by: Joao G. Porto, et al.
Published: (2024-03-01)

Surveillance Colonoscopy Revealing Asymptomatic Low-Grade Appendiceal Mucinous Neoplasm
by: Jagmeet S. Grewal, et al.
Published: (2021-01-01)

Revolutionizing prostate cancer care: Unravelling the effects of varied surveillance intensities on treatment quality and patient well-being.
by: Anika Rastogi
Published: (2024-08-01)

How to use new transrectal ultrasound in prostate cancer detection and biopsy for beginners and experts
by: Byung Kwan Park
Published: (2025-03-01)

Incorporating the NICE Cambridge Prognostic Groups and Predict Prostate into a structured informed‐decision making clinic reduces over‐treatment rates of early prostate cancer
by: Vincent J. Gnanapragasam, et al.
Published: (2025-06-01)

Modern Approach in Radiological Diagnosis of Prostate Cancer (Systematic Review of International Clinical Guidelines and Clinical Studies Over 2014–2020)
by: A. V. Vasilyev, et al.
Published: (2021-01-01)

The Effect of Pre-Biopsy Prostate MRI on the Congruency and Upgrading of Gleason Grade Groups Between Prostate Biopsy and Radical Prostatectomy
by: Peter Stapleton, et al.
Published: (2024-12-01)

Tolerability of Transperineal Prostate Biopsy Under Local Anaesthetic Using Pre-Emptive Over-the-Counter Analgesia: An Interventional Study in Patients with Abnormal Clinical Prostate Findings
by: Shelley Ting-Li Wang, et al.
Published: (2024-12-01)

Added value of multifrequency magnetic resonance elastography in predicting pathological grading of pancreatic neuroendocrine neoplasms
by: Jiaxin Yuan, et al.
Published: (2025-06-01)

Predictive Value of Multiparametric Magnetic Resonance Imaging (T2-weighted Imaging and Apparent Diffusion Coefficient) for Pathological Grading of Prostate Cancer: a Meta-Analysis
by: Subo Zhang, et al.
Published: (2025-04-01)

Early abduction treatment versus observation in Barlow-positive and mildly unstable hips
by: Vilma Lankinen, et al.
Published: (2025-08-01)

Exploring innovative models of surgical treatment for rectal cancer
by: LI Xinxiang, LUO Dakui
Published: (2025-07-01)

“Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use
by: E. V. Borodavina, et al.
Published: (2024-04-01)